Elliot Norry
Chief Tech/Sci/R&D Officer at ADAPTIMMUNE THERAPEUTICS PLC
Net worth: 86 443 $ as of 2024-03-30
Profile
Elliot Norry is currently the Chief Medical Officer at Adaptimmune Therapeutics Plc since 2020.
Prior to this, he worked as a Director at Covenant Financial, Inc. Dr. Norry completed his undergraduate degree at Columbia College (MO) and holds a doctorate degree from New York University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-01-16 | 257,165 ( 0.05% ) | 67 735 $ | 2024-03-30 | |
| 2024-01-11 | 11,841 ( 0.00% ) | 18 709 $ | 2024-03-30 |
Elliot Norry active positions
| Companies | Position | Start |
|---|---|---|
| ADAPTIMMUNE THERAPEUTICS PLC | Chief Tech/Sci/R&D Officer | 2019-12-31 |
Former positions of Elliot Norry
| Companies | Position | End |
|---|---|---|
Covenant Financial, Inc.
 Covenant Financial, Inc. Financial ConglomeratesFinance Covenant Financial, Inc. engages in the provision of commercial banking services. The company was founded in 2015 and is headquartered in Doylestown, PA. | Director/Board Member | - |
Training of Elliot Norry
| Columbia College (MO) | Undergraduate Degree |
| New York University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ADAPTIMMUNE THERAPEUTICS PLC | Health Technology |
| Private companies | 1 |
|---|---|
Covenant Financial, Inc.
Covenant Financial, Inc. Financial ConglomeratesFinance Covenant Financial, Inc. engages in the provision of commercial banking services. The company was founded in 2015 and is headquartered in Doylestown, PA. | Finance |
- Stock Market
- Insiders
- Elliot Norry
